Mariusz Kusztal
Biographic Data
| ID | 7865477 |
|---|---|
| NAME | Mariusz Kusztal |
| GIVEN NAMES | Mariusz |
| FAMILY NAME | Kusztal |
| SIGNATURE | KUSZTAL M |
| AFFILIATIONS | Wroclaw Medical University |
| ORCID | 0000-0002-6502-0374 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Considerations for Home-Based Treatment of Fabry Disease in Poland during the Covid-19 Pandemic and Beyond
Current therapy for Anderson-Fabry disease in Poland includes hospital or clinic-based intravenous enzyme replacement therapy with recombinant agalsidase alpha or beta, or oral pharmacological chaperone therapy with migalastat. Some countries around the world offer such treatment to patients in the comfort of their own homes. The 2020-2021 COVID-19 pandemic has pushed global healthcare providers to evolve their services so as to minimize the risk…
Assessment of Depression and Anxiety in Patients with Chronic Kidney Disease and after Kidney Transplantation—A Comparative Analysis
Depression and anxiety are common among chronic kidney disease (CKD) patients but are rarely diagnosed and treated. Furthermore, the fraction of patients with depression is greater among hemodialyzed patients. The aim of the study was to assess the prevalence of depression symptoms, anxiety and assess the level of life satisfaction in three groups of patients based on the stage of CKD. The study group consisted of 283 patients-130 females and 153…
No prominent works on this page.
Considerations for Home-Based Treatment of Fabry Disease in Poland during the Covid-19 Pandemic and Beyond
Current therapy for Anderson-Fabry disease in Poland includes hospital or clinic-based intravenous enzyme replacement therapy with recombinant agalsidase alpha or beta, or oral pharmacological chaperone therapy with migalastat. Some countries around the world offer such treatment to patients in the comfort of their own homes. The 2020-2021 COVID-19 pandemic has pushed global healthcare providers to evolve their services so as to minimize the risk…
Assessment of Depression and Anxiety in Patients with Chronic Kidney Disease and after Kidney Transplantation—A Comparative Analysis
Depression and anxiety are common among chronic kidney disease (CKD) patients but are rarely diagnosed and treated. Furthermore, the fraction of patients with depression is greater among hemodialyzed patients. The aim of the study was to assess the prevalence of depression symptoms, anxiety and assess the level of life satisfaction in three groups of patients based on the stage of CKD. The study group consisted of 283 patients-130 females and 153…
Disease (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Anxiety (1 work) · Bioinformatics (1 work) · Carbohydrate Chemistry and Synthesis (1 work) · Coronavirus disease 2019 (COVID-19 (1 work) · Depression (economics (1 work) · Dialysis and Renal Disease Management (1 work) · Enzyme replacement therapy (1 work)